Literature DB >> 10617873

Dysregulated expression of growth factors and their receptors in the development of prostate cancer.

D Djakiew1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10617873     DOI： 10.1002/(sici)1097-0045(20000201)42:2<150::aid-pros10>3.0.co;2-h

Source DB:  PubMed          Journal:  Prostate        ISSN： 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  29 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

Review 2.  CYP17A1 inhibitors in castration-resistant prostate cancer.

Authors:  Lissette Gomez; Jason R Kovac; Dolores J Lamb
Journal:  Steroids       Date:  2015-01-03       Impact factor: 2.668

Review 3.  Tumour innervation and neurosignalling in prostate cancer.

Authors:  Brayden March; Sam Faulkner; Phillip Jobling; Allison Steigler; Alison Blatt; Jim Denham; Hubert Hondermarck
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

4.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Authors:  Liza Barki-Harrington; Angela L Bookout; Gaofeng Wang; Maria E Lamb; L M Fredrik Leeb-Lundberg; Yehia Daaka
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  Expression of the Bcl-2 protein BAD promotes prostate cancer growth.

Authors:  Adrienne J Smith; Yelena Karpova; Ralph D'Agostino; Mark Willingham; George Kulik
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

7.  Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.

Authors:  Malathy P V Shekhar; Steven Santner; Kathryn A Carolin; Larry Tait
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

9.  Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Authors:  Ferenc G Rick; Andrew Abi-Chaker; Luca Szalontay; Roberto Perez; Miklos Jaszberenyi; Arumugam R Jayakumar; Nagarajarao Shamaladevi; Karoly Szepeshazi; Irving Vidaurre; Gabor Halmos; Awtar Krishan; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

Review 10.  Signaling inhibitors in the treatment of prostate cancer.

Authors:  Gary R Hudes
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.